387 related articles for article (PubMed ID: 21276828)
1. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
[TBL] [Abstract][Full Text] [Related]
2. Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.
Moreno JL; Holloway T; Rayannavar V; Sealfon SC; González-Maeso J
Neurosci Lett; 2013 Mar; 536():69-73. PubMed ID: 23333599
[TBL] [Abstract][Full Text] [Related]
3. Role of mGlu2 in the 5-HT
Hideshima KS; Hojati A; Saunders JM; On DM; de la Fuente Revenga M; Shin JM; Sánchez-González A; Dunn CM; Pais AB; Pais AC; Miles MF; Wolstenholme JT; González-Maeso J
Psychopharmacology (Berl); 2018 Nov; 235(11):3149-3165. PubMed ID: 30209534
[TBL] [Abstract][Full Text] [Related]
4. Chronic treatment with a metabotropic mGlu2/3 receptor agonist diminishes behavioral response to a phenethylamine hallucinogen.
Halberstadt AL; van der Zee JVF; Chatha M; Geyer MA; Powell SB
Psychopharmacology (Berl); 2019 Feb; 236(2):821-830. PubMed ID: 30448990
[TBL] [Abstract][Full Text] [Related]
5. N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
Lee MY; Chiang CC; Chiu HY; Chan MH; Chen HH
Neuropharmacology; 2014 Jun; 81():215-23. PubMed ID: 24534112
[TBL] [Abstract][Full Text] [Related]
6. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
[TBL] [Abstract][Full Text] [Related]
7. Identification of a serotonin/glutamate receptor complex implicated in psychosis.
González-Maeso J; Ang RL; Yuen T; Chan P; Weisstaub NV; López-Giménez JF; Zhou M; Okawa Y; Callado LF; Milligan G; Gingrich JA; Filizola M; Meana JJ; Sealfon SC
Nature; 2008 Mar; 452(7183):93-7. PubMed ID: 18297054
[TBL] [Abstract][Full Text] [Related]
8. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
González-Maeso J; Yuen T; Ebersole BJ; Wurmbach E; Lira A; Zhou M; Weisstaub N; Hen R; Gingrich JA; Sealfon SC
J Neurosci; 2003 Oct; 23(26):8836-43. PubMed ID: 14523084
[TBL] [Abstract][Full Text] [Related]
9. HSV-Mediated Transgene Expression of Chimeric Constructs to Study Behavioral Function of GPCR Heteromers in Mice.
Holloway T; Moreno JL; González-Maeso J
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501227
[TBL] [Abstract][Full Text] [Related]
10. Modulation of DOM-Induced Head-Twitch Response by mGluR2 Agonist/Inverse Agonist is Associated with 5-HT
Gao H; Liu X; Xie L; Tan B; Su R
Neurochem Res; 2024 Mar; 49(3):636-648. PubMed ID: 37989895
[TBL] [Abstract][Full Text] [Related]
11. Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.
Moreno JL; Kurita M; Holloway T; López J; Cadagan R; Martínez-Sobrido L; García-Sastre A; González-Maeso J
J Neurosci; 2011 Feb; 31(5):1863-72. PubMed ID: 21289196
[TBL] [Abstract][Full Text] [Related]
12. Interclass GPCR heteromerization affects localization and trafficking.
Toneatti R; Shin JM; Shah UH; Mayer CR; Saunders JM; Fribourg M; Arsenovic PT; Janssen WG; Sealfon SC; López-Giménez JF; Benson DL; Conway DE; González-Maeso J
Sci Signal; 2020 Oct; 13(654):. PubMed ID: 33082287
[TBL] [Abstract][Full Text] [Related]
13. Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice.
Halberstadt AL; Lehmann-Masten VD; Geyer MA; Powell SB
Psychopharmacology (Berl); 2011 May; 215(1):81-92. PubMed ID: 21153406
[TBL] [Abstract][Full Text] [Related]
14. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
[TBL] [Abstract][Full Text] [Related]
15. Hallucinogens and Serotonin 5-HT
López-Giménez JF; González-Maeso J
Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
[TBL] [Abstract][Full Text] [Related]
16. Tolerance and Cross-Tolerance among Psychedelic and Nonpsychedelic 5-HT
de la Fuente Revenga M; Jaster AM; McGinn J; Silva G; Saha S; González-Maeso J
ACS Chem Neurosci; 2022 Aug; 13(16):2436-2448. PubMed ID: 35900876
[TBL] [Abstract][Full Text] [Related]
17. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.
Santini MA; Balu DT; Puhl MD; Hill-Smith TE; Berg AR; Lucki I; Mikkelsen JD; Coyle JT
Behav Brain Res; 2014 Feb; 259():242-6. PubMed ID: 24269270
[TBL] [Abstract][Full Text] [Related]
18. Persistent effects of chronic clozapine on the cellular and behavioral responses to LSD in mice.
Moreno JL; Holloway T; Umali A; Rayannavar V; Sealfon SC; González-Maeso J
Psychopharmacology (Berl); 2013 Jan; 225(1):217-26. PubMed ID: 22842765
[TBL] [Abstract][Full Text] [Related]
19. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
20. Differential signaling signatures evoked by DOI versus lisuride stimulation of the 5-HT
Banerjee AA; Vaidya VA
Biochem Biophys Res Commun; 2020 Oct; 531(4):609-614. PubMed ID: 32814630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]